EGFR and metabolic dysfunction-associated steatotic liver disease: We firstly detected the protein expression of EGFR in metastatic CRC tissues via immunohistochemistry (IHC) and western blot assays, and the results showed that EGFR density was higher in the NAFLD group (Fig. 4A, B).